Anova and Nouveau Team Up on Kromastat Development
CAMBRIDGE, Mass., July 17, 2026 Anova and Nouveau Biosciences announced a strategic partnership to conduct clinical development of Kromastat...
Phase 1 trial
Advertisement
Cellectar Publishes Phase 1 Iopofosine Data
FLORHAM PARK, N.J., July 15, 2026 Cellectar Biosciences announced the publication of results from its Phase 1 dose-escalation study...
Atea Pharmaceuticals Starts Phase 1 AT-587 Trial
BOSTON, July 14, 2026 Atea Pharmaceuticals announced the initiation of a first-in-human Phase 1 clinical trial evaluating AT-587, an...
Zelluna Doses First Patient With TCR-NK Therapy
OSLO, Norway, July 13, 2026 Zelluna announced that the first patient has been dosed in the ZIMA-101 Phase 1...
Erasca Moves ERAS-0015 Into Late-Stage Development
SAN DIEGO, July 13, 2026 Erasca announced updated preliminary Phase 1 data for its investigational pan-RAS molecular glue ERAS-0015,...
Advertisements
Immutep Reports Positive INSIGHT-003 Survival Data
SYDNEY, Australia, July 13, 2026 Immutep announced positive mature overall survival data from its investigator-initiated Phase 1 INSIGHT-003 trial...
Vandria Reports Positive Phase 1 VNA-318 Data
LAUSANNE, Switzerland, July 13, 2026 Vandria announced new Phase 1 clinical data demonstrating that its investigational small molecule VNA-318...
IN8bio Publishes Positive Phase 1 GBM Data
NEW YORK, July 9, 2026 IN8bio announced the publication of peer-reviewed Phase 1 clinical trial results for its investigational...
AB Science Prioritizes AML and ALS Programs
PARIS, July 10, 2026 AB Science announced a major strategic update to its clinical development pipeline, confirming that it...
MetaVia Advances DA-1726 Phase 1 Obesity Trial
CAMBRIDGE, Mass. | July 9, 2026 MetaVia Inc., a clinical-stage biotechnology company focused on developing innovative therapies for cardiometabolic...
Advertisement
